Business Context and Reporting Period
Company: Novo Nordisk A/S
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date: June 29, 2026
Subject: Update on Share Repurchase Programme
Novo Nordisk is a leading global healthcare company headquartered in Denmark, employing approximately 67,900 people across 80 countries. The filing reports on the execution of a share repurchase programme initiated on May 6, 2026, under the EU Market Abuse Regulation (MAR) Safe Harbour Rules.
Key Financial Metrics and Capital Allocation
This filing focuses on capital allocation via share buybacks rather than operational financial performance (revenue, profit, or cash flow). Key metrics include:
- Total Repurchase Programme Cap: Up to DKK 15 billion over a 12-month period starting February 4, 2026.
- Specific Programme (May 6, 2026): Up to DKK 11,200,000,010.45 for B shares.
- Cumulative Repurchases (Since Feb 4, 2026): 22,009,179 B shares.
- Average Purchase Price (Cumulative): DKK 268.02 per B share.
- Total Transaction Value (Cumulative): DKK 5,898,848,910.
- Treasury Shares Held: 39,194,480 B shares (0.9% of total share capital).
Material Changes and Recent Activity
The filing details transactions executed between June 22, 2026, and June 26, 2026, following an announcement on June 22. During this specific window, the company repurchased 850,000 B shares.
| Date | Shares Purchased | Avg. Price (DKK) | Transaction Value (DKK) |
|---|---|---|---|
| June 22, 2026 | 220,000 | 291.32 | 64,091,259 |
| June 23, 2026 | 210,000 | 306.05 | 64,269,567 |
| June 24, 2026 | 210,000 | 309.81 | 65,060,127 |
| June 25, 2026 | 210,000 | 314.91 | 66,131,566 |
| June 26, 2026 | 200,000 | 311.46 | 62,291,224 |
Accumulated under the May 6 programme: 7,250,000 shares for DKK 2,098,848,921.
Guidance, Outlook, and Risks
Outlook: Novo Nordisk expects to continue repurchasing B shares up to the total programme limit of DKK 15 billion during the 12-month period beginning February 4, 2026. As of June 26, 2026, approximately DKK 9.1 billion remains available under the total programme cap.
Risks and Contingencies: The filing does not disclose new operational risks, contingencies, or unusual items. It strictly adheres to regulatory reporting requirements for share buybacks under the Safe Harbour Rules.
Investor Verification Checklist
- Verify the remaining capacity under the DKK 15 billion total programme (approx. DKK 9.1 billion).
- Confirm the current market price of B shares relative to the recent average purchase price of DKK 268.02.
- Review the total number of treasury shares (39,194,480) against the total share capital (4,465,000,000) to assess dilution impact.
- Check subsequent filings for any acceleration or suspension of the buyback programme.